Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Orgenesis Inc (ORGS)

Orgenesis Inc (ORGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Tri Pointe: Q2 Earnings Snapshot

Tri Pointe: Q2 Earnings Snapshot

ORGS : 0.5550 (unch)
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies

Strategic Acquisition Designed to Expand Access to Cost-Effective, Scalable Regenerative Medicine Treatments

ORGS : 0.5550 (unch)
Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings

Funding Aimed at Accelerating Rollout of Decentralized CGT Platform

ORGS : 0.5550 (unch)
Orgenesis Provides Third Quarter 2024 Business Update

ORGS : 0.5550 (unch)
Orgenesis Commences Trading on OTCQX® Best Market

ORGS : 0.5550 (unch)
Orgenesis Achieves Revenue of $7.2 Million for the First Quarter of 2022

GERMANTOWN, Md., May 24, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...

ORGS : 0.5550 (unch)
Orgenesis Led Consortium Awarded €4M European Innovation Council Pathfinder Grant

Focus is to Develop Cost-effective Production of Autologous Induced Pluripotent Stem Cells (iPSCs) using Microfluidic Technologies and Artificial...

ORGS : 0.5550 (unch)
Orgenesis Reports Revenue Growth of 364% for 2021 and Provides Business Update

Orgenesis to host conference call today at 12:00 PM ET...

ORGS : 0.5550 (unch)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...

VMAR : 2.48 (+0.40%)
FLGC : 8.95 (-18.41%)
VIRI : 0.1550 (+12.40%)
ZIVO : 9.2500 (-1.60%)
FAU.AX : 0.016 (+6.67%)
GBLX : 0.0003 (unch)
VEV : 0.0201 (-58.30%)
TBRD.VN : 1.710 (+2.40%)
XXII : 3.83 (-4.01%)
GOVX : 1.6500 (-3.51%)
OSS.VN : 0.870 (unch)
RCRT : 2.74 (+7.03%)
Orgenesis to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021

GERMANTOWN, MD / ACCESSWIRE / August 12, 2021 / Orgenesis Inc. (NASDAQ:ORGS), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting...

ORGS : 0.5550 (unch)

Barchart Exclusives

South Korea’s Stock Market Just Fell 12% in 1 Day. Here's What It Means for Investors.
The iShares MSCI South Korea ETF (EWY) just experienced a sudden dramatic drop. Here's what to know about what happened and what it means for U.S. investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar